Graphic version of this page | Change how these pages look
Home←Clinical support←Formulary←Ledipasvir/sofosbuvir 90mg/400mg tablets (Harvoni®)
Ledipasvir/sofosbuvir 90mg/400mg tablets (Harvoni®)
NHSE clinical commissioning policy statement: Treatment of chronic hepatitis C in patients with cirrhosis
- Traffic Light
Red
- BNF
5.3.3.2
- Licensed Indicators
Treatment of chronic hepatitis C in adullts
- Reference
APC Jan 15, Sep 15
- Criteria
- Provisional
No
Do you want to add this to your CPD record?
Did you find this page helpful?
© 2024
Website by Sitekit, body system icons designed by Freepik